• Deutsch
  • English
Astro-Pharma Austria Therapiestandards für Sie!  -  Astro Pharma, Österreich
  • Home
  • Products
    • Antibiotics
    • Biosimilars
    • Vaccines
    • IVF-Products
  • Company
    • The company
    • History
    • Network
    • Transparency
  • Team
    • Management
    • Back Office
    • Key Account & Sales Manager
    • Consultants
  • News & Info
  • Service
  • Contact
  • Maximum flexibility, total commitment, great team spirit –
    these are the maxims we live by for our mutual success!

    Mag. Helmut Kaisergruber, Founder of the company, Managing Director and responsible for
    key business and business development
  • We offer our customers innovative solutions in the area of
    IVF by working closely with international partners.

    Virginie Gierszewski, IVF-Manager
  • My customers appreciate Astro Pharma’s flexible,
    professionally competent and solution-orientated
    collaboration, coupled with outstanding customer service.

    Walter Diermayr, sales representative in Carinthia
Celltrion Covid-19 Ag Test DiaTrust™
Corona antigen rapid test with easy handling and fast result

PZN: 5415929
Astro Pharma offers a high quality COVID-19 antigen rapid test (LFIA = lateral flow immunochromatographic assay using swab from nasopharynx) with easy handling.
The test has a clinical specificity of 100% and a clinical sensitivity of 95.5%.
The buffer solution, pre-filled per test in a sample tube, eliminates the laborious step of applying the buffer solution from a larger container and makes each of the under-packaged individual tests a stand-alone test unit.
The Celltrion Covid-19 Ag Test was developed by our long-time partner company Celltrion of South Korea in collaboration with Humasis.

For further product information and ordering please contact our ordering department:
phone: +43 (1) 961 9313
fax: +43 (1) 961 9314
e-maill: bestellungen[at]astropharma.at

Home

News & Infos
The Biosimilars Association Austria warns of end of biosimilars price regulation at the end of the year
The 4 years of biosimilars price regulation in Austria have proven successful. Since April 2017, 22 biosimilars have been included in the reimbursement code, saving approximately EUR 247 million (2017-2019)....
[Read more here]
Our new CSR Report
Astro Pharma presents the new CSR Report 2020.
[Read more here]
Annual meeting of the Austrian Society for Reproductive Medicine and the in-vitro fertilisation Society
From 8. until 10. of October 2020 the annual meeting of the Austrian Society for Reproductive Medicine and the in-vitro fertilisation Society took place in Mauerbauch, close to Vienna. Astro...
[Read more here]
Increasing the value of Biosimilars
The austrian scientific magazine „Österreichische Apothekerzeitung” published an article about „Increasing the value of Biosimilars”. This document outlines the benefits of Biosimilars in enabling affordable treatment and widening patient access...
[Read more here]
A new patient information material for a better awareness of Biosimilars
On the 22nd of September 2020 Dr. Sabine Möritz-Kaisergruber introduced a new patient information material concerning Biosimilars at a press conference. [Press release (in german)] [patient information material (in 8...
[Read more here]
imh Conference 2020 on Biosimilars 29.-30.09.2020
On 29. – 30. 9. 2020, the imh would like to invite you to the pharmaceutical forum based on the biosimilar topics: market penetration / regulations / reimbursement. Specialists from...
[Read more here]
Potential for savings through the usage of biosimillars
New Austrian Study of Biosimilars Association Austria proves: Around EUR 357 million savings through biosimilars in the last 12 years
[Read more here]
Information for patients on Biosimilars 2016
This edition of information for patients on biosimilars was prepared jointly by representatives of the European Medicines Agency (EMA), the European Commission and corresponding third parties.
[Read more here]
Products

Antibiotics

Biosimilars

Vaccines

IVF-Products

Our international network
Our international network
Products
Astropharma Products
Our Company
Astropharma our Company
Astro Pharma
Astro Pharma is a family-run business from Austria and consists of 30 pharmaceutical professionals who know the Austrian market like no other. We specialise in innovative and economical drugs and niche products which are indispensable for the health system of the future and can take the strain off it permanently. We offer our own products such as antibiotics and vaccines and are general agents in Austria for international drug companies. An international network combined with unique local knowledge prepare us for any challenge: With our outstanding service and product range, we start where others reach their limits
Astro Pharma – We introduce ourselves!

Video not supported.

Biosimilarsverband
Sales of biosimilars
Astro Pharma is a founding member of the Austrian Biosimilar Association (BiVÖ). Astro Pharma and other members of the Association, A-med GmbH, ratiopharm Arzneimittel Vertriebs GmbH, Sandoz GmbH and STADA Arzneimittel GmbH, account for more than 85% of the Austrian biosimilar market. The president of the voluntary lobby group of biosimilar providers and producers is Sabine Möritz-Kaisergruber, Managing Partner of Astro Pharma. The Austrian Biosimilar Association was founded in 2016 and is committed to providing the best care for Austrian patients with top-quality biopharmaceutical drugs at affordable prices. Biosimilars are biological drugs which can significantly take the strain off the healthcare system because of their consistent quality, safety and effectiveness. For more information about the Austrian Biosimilar Association, please visit: www.biosimilarsverband.at More information: www.biosimilarsverband.at
biosimilarsverband
Contact
Astro Pharma Vertrieb und Handel von pharmazeutischen Produkten GmbH
Management
  • Wolfgang-Pauli-Gasse 5, 1140 Wien
  • Tel.: +43 (1) 979 9860
  • Fax: +43 (1) 979 2540
  • office[at]astropharma.at
Logistics
  • Allerheiligenplatz 4, 1200 Wien
  • Tel.: +43 (1) 961 9313
  • Fax: +43 (1) 961 9314
  • bestellungen[at]astropharma.at
Advanced/Austria
Führungszertifikat 2016
Führungszertifikat 2016
  • Contact
  • Imprint
  • Legal disclaimer
  • Links